This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure Europe

Savings End Soon

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
21-22 October, 2025
Hotel Palace BerlinBerlin, Germany
Group RatesBook Now
Menu
Book Now
Group Rates

EU CTIS

2025 marks the end of a three year period where clinical trials were transitioned to CTR through the EU Clinical Trials Information System (CTIS). Key changes include the launch of a clinical trial map in March 2025, supporting the Accelerating Clinical Trials in the EU (ACT EU) initiative. Clinical Data Disclosure Europe provides the analysis and insights required to navigate the transition and the subsequent impacts.

Practical Operational Strategies to Manage CTIS Requirements

Hear from Radek Grabowski, Head of Registries, Clinical Trial Transparency at AstraZeneca to get a sense of how Clinical Data Disclosure Europe supports you in navigating CTIS in a 5 minute preview from a previous session.

Watch Session